Skip to main content
Clinical Trials/NCT04076904
NCT04076904CompletedNot Applicable

Cesarean Niche Examination by us to Assess Its Integrity and Dehescence

Aljazeera Hospital2 sites in 1 country110 target enrollmentStarted: October 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
110
Locations
2
Primary Endpoint
The number of women who will have dehesent scar

Study Overview

Brief Summary

The developed uterine scar developing due to cesarean section is usually clinically evaluated and visualized by transvaginal sonography (TVS) and saline infusion sonography (SIS) or Gel installation sonography (GIS)

Detailed Description

In 2015, WHO displayed and reveled a systematic review of the research studies in the scientific literature to evaluate and asses the linkage and connection between cesarean section rates and maternal

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
20 Years to 42 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • women with secondary infertility

Exclusion Criteria

  • obstructed labor, pregnant women having chronic diseases;

Outcomes

Primary Outcomes

The number of women who will have dehesent scar

Time Frame: within a week

transvaginal us showing lower segment with assessing scar

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahmoud Alalfy

Researcher , lecturer ,Obstetrics and Gynecology , National Research Centre

Aljazeera Hospital

Study Sites (2)

Loading locations...

Similar Trials